A unidirectional porous beta-tricalcium phosphate material (Affinos®) for reconstruction of bony defects after excision of fibular bone for spinal surgery graft

被引:8
|
作者
Noguchi, Hiroshi [1 ]
Funayama, Toru [1 ]
Koda, Masao [1 ]
Iijima, Yasushi [2 ]
Kumagai, Hiroshi [1 ]
Ishikawa, Tetsuhiro [3 ]
Aiba, Atsuomi [4 ]
Abe, Tetsuya [1 ]
Nagashima, Katsuya [1 ]
Miura, Kousei [1 ]
Izawa, Shigeo [1 ]
Maki, Satoshi [5 ]
Furuya, Takeo [5 ]
Yamazaki, Masashi [1 ]
机构
[1] Univ Tsukuba, Fac Med, Dept Orthopaed Surg, Tsukuba, Ibaraki, Japan
[2] Seirei Sakura Citizen Hosp, Dept Orthoped Surg, Chiba, Japan
[3] Sanmu Med Ctr, Dept Orthoped Surg, Chiba, Japan
[4] Numazu City Hosp, Dept Orthoped Surg, Shizuoka, Japan
[5] Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chiba, Japan
基金
日本学术振兴会;
关键词
beta-tricalcium phosphate; Bone graft donor site; Bone remodeling; Regeneration of fibula; spinal fusion surgery; DONOR-SITE MORBIDITY; FREE-FLAP;
D O I
10.1016/j.jocn.2019.05.021
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The aim of this study was to elucidate the bone regeneration-inducing capability of Affinos (R), a newly developed, high-porosity unidirectional porous beta-TCP artificial bone. We compared the ability of Affinos (R) and OSferion (R), a commercially available beta-TCP product, to induce bone regeneration following implantation into bony defects left after fibula harvesting for spinal fusion surgery. Study subjects underwent surgery to harvest non-vascularized fibula grafts for spinal fusion surgery and were implanted with either Affinos (R) (19 patients) or OSferion (R) (15 patients, control group) at the defect site. The minimal and mean follow up periods were 6 and 11 months after surgery, respectively. X-rays of the lower leg taken 1-2 weeks after surgery and at the final follow-up visit were used to evaluate fibular-beta-TCP continuity and fibula defect filling ratio. There was no significant difference in radiographic continuity in the fibula between the two groups. The fibula defect filling ratio for the Affinos (R) group decreased from 0.94 +/- 0.17 at 1-2 weeks to 0.77 +/- 0.14 at 10 months. For the OSferion (R) control group, the fibula defect filling ratio decreased from 0.94 +/- 0.14 at 1-2 weeks to 0.52 +/- 0.27 at final follow-up. The Affinos (R) group showed a significantly higher fibula defect filling ratio compared to that for the OSferion (R) group (p = 0.003). These results indicate that Affinos (R) has slow absorption rates and significant defect filling activity compared with OSferion (R). Thus, Affinos could be a suitable substitute to fill bony defects induced by fibula harvesting for spinal reconstruction surgery. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 11 条
  • [1] Unidirectional porous beta-tricalcium phosphate as a potential bone regeneration material for infectious bony cavity without debridement in pyogenic spondylitis
    Funayama, Toru
    Noguchi, Hiroshi
    Shibao, Yosuke
    Sato, Kosuke
    Kumagai, Hiroshi
    Miura, Kousei
    Takahashi, Hiroshi
    Tatsumura, Masaki
    Koda, Masao
    Yamazaki, Masashi
    JOURNAL OF ARTIFICIAL ORGANS, 2023, 26 (01) : 89 - 94
  • [2] Unidirectional porous beta-tricalcium phosphate as a potential bone regeneration material for infectious bony cavity without debridement in pyogenic spondylitis
    Toru Funayama
    Hiroshi Noguchi
    Yosuke Shibao
    Kosuke Sato
    Hiroshi Kumagai
    Kousei Miura
    Hiroshi Takahashi
    Masaki Tatsumura
    Masao Koda
    Masashi Yamazaki
    Journal of Artificial Organs, 2023, 26 : 89 - 94
  • [3] Novel Unidirectional Porous beta-Tricalcium Phosphate Used as a Bone Substitute after Excision of Benign Bone Tumors of the Hand: A Case Series
    Ikumi, Akira
    Funayama, Toru
    Tsukanishi, Toshinori
    Noguchi, Hiroshi
    Yamazaki, Masashi
    JOURNAL OF HAND SURGERY-ASIAN-PACIFIC VOLUME, 2018, 23 (03) : 424 - 429
  • [4] Radiographic and Clinical Assessment of Unidirectional Porous Beta-Tricalcium Phosphate to Treat Benign Bone Tumors
    Kunisada, Toshiyuki
    Nakata, Eiji
    Fujiwara, Tomohiro
    Katayama, Haruyoshi
    Itano, Takuto
    Kurozumi, Takanao
    Ando, Teruhiko
    Ozaki, Toshifumi
    BIOMIMETICS, 2025, 10 (02)
  • [5] Unidirectional porous beta-tricalcium phosphate and hydroxyapatite artificial bone: a review of experimental evaluations and clinical applications
    Toru Funayama
    Hiroshi Noguchi
    Hiroshi Kumagai
    Kosuke Sato
    Tomokazu Yoshioka
    Masashi Yamazaki
    Journal of Artificial Organs, 2021, 24 : 103 - 110
  • [6] Unidirectional porous beta-tricalcium phosphate and hydroxyapatite artificial bone: a review of experimental evaluations and clinical applications
    Funayama, Toru
    Noguchi, Hiroshi
    Kumagai, Hiroshi
    Sato, Kosuke
    Yoshioka, Tomokazu
    Yamazaki, Masashi
    JOURNAL OF ARTIFICIAL ORGANS, 2021, 24 (02) : 103 - 110
  • [7] Evaluation of hydroxyapatite and beta-tricalcium phosphate mixed with bone marrow aspirate as a bone graft substitute for posterolateral spinal fusion
    Bansal, Sanjay
    Chauhan, Vijendra
    Sharma, Sansar
    Maheshwari, Rajesh
    Juyal, Anil
    Raghuvanshi, Shailendra
    INDIAN JOURNAL OF ORTHOPAEDICS, 2009, 43 (03) : 234 - 239
  • [8] Clinical Outcome of Beta-Tricalcium Phosphate Use for Bone Defects after Operative Treatment of Benign Tumors
    Chung, Haksun
    Kim, Sanghyo
    Chung, So Hak
    CLINICS IN ORTHOPEDIC SURGERY, 2019, 11 (02) : 233 - 236
  • [9] The Use of Beta-Tricalcium Phosphate and Bovine Bone Matrix in the Guided Tissue Regeneration Treatment of Deep Infra-Bony Defects
    Lukovic, Natalija
    Zelic, Obrad
    Cakic, Sasa
    Petrovic, Vanja
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2009, 137 (11-12) : 607 - 612
  • [10] Efficacy of β-Tricalcium Phosphate Graft into the Bone Defects after Bone-Patellar Tendon-Bone Anterior Cruciate Ligament Reconstruction
    Higuchi, Hiroshi
    Kobayashi, Atsushi
    Ikeda, Keiko
    Hatayama, Kazuhisa
    Yanagisawa, Sinya
    Kato, Kazuo
    JOURNAL OF KNEE SURGERY, 2017, 30 (05) : 467 - 473